Rho inhibitor Cethrin granted Orphan Drug Status by EC

Alseres have announced that Cethrin has been granted designation as an orphan medicinal product for the treatment of traumatic spinal cord injury (SCI) by the European Commission.

Incytes JAK2 inhibitor INCB18424 demonstrates POC in Psoriasis

Incyte have reported positive results from Phase IIa clinical trials of JAK2 inhibitor INCB18424 in patients with mild to moderate psoriasis.

S*BIO Initiate Phase I trial of JAK2 Inhibitor SB1518

S*BIO Pte have announced the initiation of multi-center Phase I clinical trials of JAK2 inhibitor SB1518 in patients with leukemia and certain types of lymphoma.